All In Biotech

Free tool

FAERS Monitor: Zegerid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021849 or its brand name (Zegerid, Omeprazole, Sodium Bicarbonate). Reports on generic versions are filed under their own applications.

Reports

2,739

Serious

1,742

64% of reports

Hospitalization

536

Death reported

167

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chronic kidney disease788
  • acute kidney injury456
  • renal failure431
  • end stage renal disease212
  • drug ineffective200
  • renal injury195
  • nausea167
  • gastrooesophageal reflux disease156
  • pain135
  • headache131
  • fatigue126
  • diarrhoea109
  • tubulointerstitial nephritis101
  • dyspnoea90
  • anxiety87

Reports by year received

View as table
YearReports
20057
200614
200726
200862
200986
2010119
2011145
2012142
2013102
201497
2015148
2016150
2017172
2018301
2019513
2020187
2021153
2022101
202345
202472
202558
202639

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,420 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
end stage renal diseaseSignal21290.379.318,432
chronic kidney diseaseSignal78880.575.861,341
renal injurySignal19550.744.39,407
tubulointerstitial nephritisSignal10141.634.33,944
renal failureSignal43125.022.99,937
acute kidney injurySignal45622.921.19,591
gastrooesophageal reflux diseaseSignal15614.912.82,014
anxietySignal872.31.967
pain1351.71.438
nausea1671.61.441
headache1311.61.430
diarrhoea1091.31.17
fatigue1261.21.06
dyspnoea901.21.03
drug ineffective2001.21.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.